Jae Kim
PartnerEXPERIENCE
- Korean
- J.D., University of Notre Dame Law School
- Editor in Chief, Notre Dame Journal of Law, Ethics & Public Policy
- Notre Dame Moot Court Board
- B.A., Johns Hopkins University
Awards
The Legal 500 United States
- Recommended, Product Liability, Mass Tort and Class Action: Consumer Products (including Tobacco) (2022)
- Recommended, Product Liability, Mass Tort and Class Action: Pharmaceuticals and Medical Devices - Defense (2022)
For more information, pursuant to New Jersey Lawyer Advertising guidance, please click here.
Bylines
Speaking Engagements
-
Select speaking engagements include:
- Speaker, Revolutionizing clinical trials: A discussion on diversity and patient-centric approaches, At the Intersection of Science and Law Podcast, November 15, 2024
- Moderator, Pathways Toward Competitive Intelligence (featuring FDA’s Katie Gray and NAD’s Jennifer Santos), FDLI Advertising and Promotion of Medical Products Conference, October 18, 2024
- Presenter, "Decoding FDA’s Proposed ACNU Rule and Unveiling Its Implications for the OTC Industry," ACI Advanced Legal, Regulatory and Compliance Forum on OTC Drugs, January 2024
- Panelist, "Benefits and Risks of Social Media Advertising," FDLI Advertising and Promotion of Medical Products Conference, November 2023
- Moderator, "The Intersection Between FDA and Other Government Agencies," Food and Drug Law Institute (FDLI), June 13, 2023
- Panelist, "Best Practices for Implementing a Labeling Change," Advertising and Promotion Regulatory Affairs Conference – Arlington, Virginia, February 23, 2023
- Panelist, "Promoting Diversity and Inclusion through Advertising and Promotion," Food and Drug Law Institute Conference, October 2022
Memberships And Affiliations
- Food and Drug Law Institute, Conference Co-Chair, Committee Member
- Women in Bio (Philadelphia Chapter)